These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35004862)

  • 1. Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis.
    Zhang X; He X; Li Y; Xu Y; Chen W; Liu X; Hu X; Xiong L; Xu X
    Front Mol Biosci; 2021; 8():826905. PubMed ID: 35004862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis.
    Zhang X; He X; Li Y; Xu Y; Chen W; Liu X; Hu X; Xiong L; Xu X
    Front Mol Biosci; 2021; 8():702206. PubMed ID: 34859046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types.
    Wu SY; Lin KC; Lawal B; Wu ATH; Wu CZ
    Comput Struct Biotechnol J; 2021; 19():4970-4983. PubMed ID: 34584637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Comprehensive analysis of the potential immune-related biomarker transporter associated with antigen processing 1 that inhibits metastasis and invasion of ovarian cancer cells.
    Li X; Zeng S; Ding Y; Nie Y; Yang M
    Front Mol Biosci; 2022; 9():984209. PubMed ID: 36120547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-Small-Cell Lung Cancer.
    Gan J; Meng Q; Li Y
    Front Mol Biosci; 2021; 8():653454. PubMed ID: 33928124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Systematic analysis of MCM3 in pediatric medulloblastoma
    Cao L; Zhao Y; Liang Z; Yang J; Wang J; Tian S; Wang Q; Wang B; Zhao H; Jiang F; Ma J
    Front Mol Biosci; 2022; 9():1076243. PubMed ID: 36452454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer.
    Thomopoulou K; Papadaki C; Monastirioti A; Koronakis G; Mala A; Kalapanida D; Mavroudis D; Agelaki S
    Front Mol Biosci; 2024; 11():1413164. PubMed ID: 38715706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer.
    Wang Z; Jia L; Yushu Sun ; Li C; Zhang L; Wang X; Chen H
    Front Mol Biosci; 2021; 8():727347. PubMed ID: 34527704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: A DNA Methylation-Based Panel for the Prognosis and Diagnosis of Patients With Breast Cancer and Its Mechanisms.
    Frontiers Production Office
    Front Mol Biosci; 2020; 7():596445. PubMed ID: 33282913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: The Immune System in Transfusion-Related Acute Lung Injury Prevention and Therapy: Update and Perspective.
    Guo K; Ma S
    Front Mol Biosci; 2021; 8():720653. PubMed ID: 34513926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MXD3 regulation of DAOY cell proliferation dictated by time course of activation.
    Ngo T; Barisone GA; Lam KS; Dίaz E
    BMC Cell Biol; 2014 Jul; 15():30. PubMed ID: 25053245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():1047151. PubMed ID: 36325327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma.
    Ngo T; Corrales A; Bourne T; Elmojahid S; Lam KS; Díaz E
    Front Mol Biosci; 2019; 6():5. PubMed ID: 30838212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy.
    Thomas RG; Surendran SP; Jeong YY
    Front Mol Biosci; 2021; 8():693909. PubMed ID: 34026853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: The Cellular Functions and Molecular Mechanisms of G-Quadruplex Unwinding Helicases in Humans.
    Liu Y; Zhu X; Wang K; Zhang B; Qiu S
    Front Mol Biosci; 2021; 8():833430. PubMed ID: 35127827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MXD3 in proliferation of DAOY human medulloblastoma cells.
    Barisone GA; Ngo T; Tran M; Cortes D; Shahi MH; Nguyen TV; Perez-Lanza D; Matayasuwan W; Díaz E
    PLoS One; 2012; 7(7):e38508. PubMed ID: 22808009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases.
    Kong G; Lee H; Tran Q; Kim C; Park J; Kwon SH; Kim SH; Park J
    Front Mol Biosci; 2021; 8():639164. PubMed ID: 33842543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA.
    Duong C; Yoshida S; Chen C; Barisone G; Diaz E; Li Y; Beckett L; Chung J; Antony R; Nolta J; Nitin N; Satake N
    Pediatr Res; 2017 Sep; 82(3):527-535. PubMed ID: 28419087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides.
    Scala MC; Di Micco S; Lanzillotta D; Musella S; Di Sarno V; Parrino B; Cascioferro SM; Bifulco G; Trapasso F; Campiglia P; Sala M
    Front Mol Biosci; 2022; 9():915838. PubMed ID: 35573730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: KODAMA exploratory analysis in metabolic phenotyping.
    Zinga MM; Abdel-Shafy EA; Melak T; Vignoli A; Piazza S; Zerbini LF; Tenori L; Cacciatore S
    Front Mol Biosci; 2023; 10():1165720. PubMed ID: 36968275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.